Anzeige
Erschienen in:
01.04.2015 | Original article
Radical prostatectomy versus external beam radiotherapy for localized prostate cancer
Comparison of treatment outcomes
Erschienen in: Strahlentherapie und Onkologie | Ausgabe 4/2015
Einloggen, um Zugang zu erhaltenAbstract
Purpose
We retrospectively compared the treatment outcomes of localized prostate cancer between radical prostatectomy (RP) and external beam radiotherapy (EBRT).
Materials and methods
We retrospectively analyzed 738 patients with localized prostate cancer who underwent either RP (n = 549) or EBRT (n = 189) with curative intent at our institution between March 2001 and December 2011. Biochemical failure was defined as a prostate-specific antigen (PSA) level of ≥ 0.2 ng/ml in the RP group and the nadir of + ≥ 2 ng/ml in the EBRT group.
Results
The median (range) follow-up duration was 48.8 months (0.7–133.2 months) and 48.7 months (1.0–134.8 months) and the median age was 66 years (45–89 years) and 71 years (51–84 years; p < 0.001) in the RP and EBRT groups, respectively. Overall, 21, 42, and 36 % of patients in the RP group, and 15, 27, and 58 % of patients in the EBRT group were classified as low, intermediate, and high risk, respectively (p < 0.001). Androgen-deprivation therapy was more common in the EBRT group (59 vs. 27 %, respectively; p < 0.001). The 8-year biochemical failure-free survival rates were 44 and 72 % (p < 0.001) and the disease-specific survival rates were 98 % and 97 % (p = 0.543) in the RP and EBRT groups, respectively.
Conclusions
Although the EBRT group included more high-risk patients than did the RP group, the outcomes of EBRT were not inferior to those of RP. Our data suggest that EBRT is a viable alternative to RP for treating localized prostate cancer.